Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy

Diabetologia

Volumn 48, Issue 8, 2005, Pages 1585-1589

  Tan, G D ^a   Debard, C ^b   Funahashi, T ^c   Humphreys, S M ^a   Matsuzawa, Y ^c   Frayn, K N ^a   Karpe, F ^a   Vidal, H ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITÉ LYON 1   (France)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adipokines; Human metabolism; Insulin resistance; PPAR ; Rosiglitazone; Thiazoles; Thiazolidinediones

Indexed keywords

ADIPONECTIN; FATTY ACID; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INSULIN SENSITIVITY; MUSCLE BLOOD FLOW; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; UPREGULATION;

ADIPOSE TISSUE; ADULT; AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; ORGAN SPECIFICITY; RECEPTORS, CELL SURFACE; REGIONAL BLOOD FLOW; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 23844511555     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1835-y     Document Type: Article

References (12)

1. Fruebis J, Tsao TS, Javorschi S et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005-2010
2. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
3. Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769
4. Maeda N, Takahashi M, Funahashi T et al (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
5. Iwaki M, Matsuda M, Maeda N et al (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655-1663
6. Chinetti G, Zawadski C, Fruchart JC, Staels B (2004) Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 314:151-158
7. Tan GD, Fielding BA, Currie JM et al (2005) The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48:83-95
8. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
9. Debard C, Laville M, Berbe V et al (2004) Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 47:917-925
10. Tsuchida A, Yamauchi T, Ito Y et al (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279:30817-30822
11. Hammarstedt A, Sopasakis VR, Gogg S, Jansson PA, Smith U (2005) Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia 48:96-104
12. Sakamoto J, Kimura H, Moriyama S et al (2000) Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem Biophys Res Commun 278:704-711